Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy (Articolo in rivista)

Type
Label
  • Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy (Articolo in rivista) (literal)
Anno
  • 2007-01-01T00:00:00+01:00 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#doi
  • 10.1136/hrt.2006.095208 (literal)
Alternative label
  • Neglia D.; De Maria R.; Masi S.; Gallopin M.; Pisani P.; Pardini S.; Gavazzi A.; L'Abbate A.; Parodi O. (2007)
    Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy
    in Heart (Lond., 1996)
    (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
  • Neglia D.; De Maria R.; Masi S.; Gallopin M.; Pisani P.; Pardini S.; Gavazzi A.; L'Abbate A.; Parodi O. (literal)
Pagina inizio
  • 808 (literal)
Pagina fine
  • 813 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
  • Aug (literal)
Rivista
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#note
  • In: Heart, vol. Aug pp. 10 - 20. BMJ Publishing Group Ltd, 2007. (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroFascicolo
  • 7 (literal)
Note
  • ISI Web of Science (WOS) (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
  • CNR Institute of Clinical Physiology, Pisa, Italy Dipartimento di Medicina Interna, Universita' di Pisa, Pisa, Italy Cardiologia-Ospedale di Prato, Prato, Italy Dipartimento Cardiovascolare, Ospedali Riuniti di Bergamo, Bergamo, Italy Scuola Superiore Sant'Anna, Pisa, Italy (literal)
Titolo
  • Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy (literal)
Abstract
  • Objective To assess whether chronic treatment with carvedilol is able to increase myocardial blood flow (MBF) and MBF reserve in idiopathic dilated cardiomyopathy (IDC). Study Design In a double-blind, placebo-controlled trial, 16 consecutive IDC patients were randomized to treatment with carvedilol up to 25 mg b.i.d (8 pts, 7 males, mean age 60iO9 years, mean LVEF 30iO%) or placebo (8 pts, 6 males, mean age 62iO9 years, mean LVEF 28iO6%, ns vs carvedilol group). Before and six months after treatment, regional MBF was measured at rest and after i.v. dipyridamole (0.56 mg/Kg in 4') by positron emission tomography and 13N-Ammonia. Exercise capacity was assessed as time duration in a maximal bicycle exercise stress test. Results Carvedilol induced a significant decrease in resting and maximal exercise heart rate and increase in exercise capacity. Absolute MBF values did not significantly change after carvedilol or placebo either at rest and during dipyridamole. In patients treated with carvedilol, dipyridamole MBF tended to improve after treatment and MBF reserve significantly increased (from 1.67iO0.63 to 2.58iO1.04, p0.001) while it remained unchanged in the placebo group (from 1.80iO0.84 to 1.77iO0.60, ns). Stress-induced regional perfusion defects decreased after carvedilol (from 38% to 15%). Conclusions Long-term treatment with carvedilol is able to significantly increase MBF reserve and to reduce the occurrence of stress induced perfusion defects suggesting a favourable effect of the drug on coronary microvascular function in patients with IDC. (literal)
Prodotto di
Autore CNR
Insieme di parole chiave

Incoming links:


Autore CNR di
Prodotto
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
Insieme di parole chiave di
data.CNR.it